Free Daily Podcast Summary
Nano Cap Podcast: Daily Summaries Delivered
by Will Tjernlund
On the Nano Cap Podcast, we dive into the unique world of publicly traded companies with a market capitalization under $50 million – the nano caps. These are not just numbers on a stock ticker; they are stories of ambition, struggle, and triumph.Each episode, I'll sit down with the leaders and visionaries behind these companies. We’ll uncover the challenges they face, the innovations they bring, and the strategies that drive them forward in a competitive market.
Latest Episodes
The most recent episodes — sign up to get AI-powered summaries of each one.
- Today20 min
Perpetuals - $PDC - Ep:087 - Nano Cap Podcast
How is Perpetuals using artificial intelligence, trader data, and derivatives technology to build products for retail traders and financial institutions? Matthew Nicoletti, Chief Strategy Officer at Perpetuals, joins Will Tjernlund on the Nano Cap Podcast to discuss AI-powered trading signals, virtual trading, perpetual futures, and the company’s fintech growth strategy.Nicoletti introduces UpsideOnly, Perpetuals’ free virtual-money trading and prediction platform, which combines paper trading, financial education, and crowd intelligence. He explains how the company analyzes trader behavior across market conditions, drawing on what he describes as a dataset of 22 billion data points. With more than 600,000 users reported at the time of the interview, Nicoletti discusses how a growing community could support stronger trading signals and further AI development.The conversation also explores Kronos X, Perpetuals’ institutional technology business, which offers white-label derivatives and perpetual-futures technology to banks and financial institutions. Nicoletti outlines why institutions might license trading infrastructure rather than build their own, along with Perpetuals’ priorities for expanding retail adoption, launching consumer products, and onboarding institutional partners.Topics covered include:AI trading signals, crowd intelligence, and financial-market predictionsUpsideOnly’s paper trading platform and approach to retail trader educationKronos X’s institutional derivatives technology and white-label licensingPerpetual futures and Perpetuals’ business beyond cryptocurrencyRetail user growth, mobile app plans, and institutional expansionFunding decisions, shareholder dilution, and building a public-company track recordPerpetuals: https://perpetuals.com/Nano Cap Podcast: https://www.nanocappod.com/DISCLAIMER - The contents of this podcast are for informational purposes only and do not constitute financial, investment, legal, or other professional advice. Listeners should not construe any information discussed as a recommendation to buy, sell, or hold any securities or investments. Always consult with a qualified financial advisor or professional before making any financial decisions. Guests may have paid to be on the podcast.
- 5 days ago26 min
GEN Restaurant Group - $GENK - Ep:086 - Nano Cap Podcast
On the Nano Cap Podcast, Will Tjernlund interviews Luke Hewko, CFO of GEN Restaurant Group ($GENK), about the company’s announced $100 million restaurant deal with Chubby Group and its plans to grow GEN Korean BBQ as a consumer packaged goods (CPG) brand.Hewko explains how GEN uses its existing restaurant supply chain to bring frozen marinated meats, including beef bulgogi and kalbi short ribs, to grocery and club retailers such as Costco, Albertsons, and Safeway. He also shares why refrigerated, ready-to-heat Korean BBQ meals are the company’s next big product bet and how GEN plans to use its remaining restaurants to test new products with diners.In this episodeHow GEN plans to transition restaurant operations to Chubby Group while retaining ownership of the GEN Korean BBQ brandWhy GEN started with frozen marinated meats and how it plans to expand beyond its West Coast retail footprintHow GEN plans to use co-packers to grow without building its own manufacturing facilitiesWhat it would take to reach GEN’s goal of a $100 million annual revenue run rate within three yearsWhat Hewko learned from launching direct-to-customer sales at Haas Automation and serving as CFO of a Bitcoin ATM operatorSubscribe to the Nano Cap Podcast for interviews with the people behind some of the smallest but mightiest publicly traded companies from around the world.GEN Restaurant Group: https://genkoreanbbq.com/Nano Cap Podcast: https://www.nanocappod.com/DISCLAIMER - The contents of this podcast are for informational purposes only and do not constitute financial, investment, legal, or other professional advice. Listeners should not construe any information discussed as a recommendation to buy, sell, or hold any securities or investments. Always consult with a qualified financial advisor or professional before making any financial decisions. Guests may have paid to be on the podcast.
- 1 weeks ago20 min
Allarity Therapeutics - $ALLR - Ep:085 - Nano Cap Podcast
Allarity Therapeutics (ALLR) CEO Thomas Jensen joins Will Tjernlund on the Nano Cap Podcast to discuss precision medicine, ovarian cancer treatment, and the development of stenoparib, an investigational oral cancer drug.Jensen explains how Allarity’s Drug Response Predictor (DRP) uses messenger RNA expression from tumor samples to identify patients who may be more likely to respond to a specific treatment. He shares the company’s origins in Danish academic research and why matching existing drugs with the right patients could create new opportunities in cancer care.The conversation explores Allarity’s Phase 2 clinical trial in advanced recurrent ovarian cancer, a VA-funded study evaluating stenoparib in small cell lung cancer, and the clinical development milestones Jensen is targeting through 2027. Jensen also discusses the role of artificial intelligence in drug development, the challenges of collecting reliable biological data, and the patient experiences that motivate his work.Topics include:Allarity Therapeutics’ precision oncology strategyStenoparib and PARP inhibitor researchDrug Response Predictor technology and cancer biomarkersOvarian cancer and small cell lung cancer clinical trialsAI, mRNA data, and personalized cancer treatmentSubscribe to the Nano Cap Podcast for conversations with the leaders behind some of the smallest but mightiest publicly traded companies from around the world.Allarity Therapeutics: https://allarity.com/Nano Cap Podcast: https://www.nanocappod.com/DISCLAIMER - The contents of this podcast are for informational purposes only and do not constitute financial, investment, legal, or other professional advice. Listeners should not construe any information discussed as a recommendation to buy, sell, or hold any securities or investments. Always consult with a qualified financial advisor or professional before making any financial decisions. Guests may have paid to be on the podcast.
- 1 weeks ago31 min
Alliance Advisors - Joe Caruso - Ep:084 - Nano Cap Podcast
Will Tjernlund welcomes Joseph “Joe” Caruso, CEO and co-founder of Alliance Advisors, to the Nano Cap Podcast for a conversation about proxy voting, shareholder communications, and retail investor engagement. Caruso explains why nano-cap and micro-cap companies can struggle to reach their own shareholders, and how those barriers can affect critical votes, capital raises, and business growth.What is the difference between an objecting beneficial owner (OBO) and a non-objecting beneficial owner (NOBO)? Caruso breaks down these shareholder classifications in plain English and shares why he is advocating for changes that would give public companies more direct access to their investors. He also explains how a company can struggle to achieve a shareholder quorum even when investors might support its proposals.The conversation explores how shareholder engagement has evolved from mailed proxy statements and phone calls to text-to-vote campaigns, email outreach, and investor communities on Reddit and Stocktwits. For smaller public companies with limited budgets, reaching shareholders efficiently can make a meaningful difference.Topics include:How proxy solicitation and shareholder voting workOBO vs. NOBO classifications and shareholder transparencyWhy retail investors matter to nano-cap and micro-cap companiesHow voting participation can affect financing and share issuanceDigital communication tools for investor relationsCaruso’s case for reforming shareholder communication rulesListen for a behind-the-scenes look at corporate governance and the role individual investors play in the future of small public companies.Subscribe to the Nano Cap Podcast for more conversations with the people behind some of the smallest but mightiest publicly traded companies from around the world.Alliance Advisors: https://allianceadvisors.com/Nano Cap Podcast: https://www.nanocappod.com/DISCLAIMER - The contents of this podcast are for informational purposes only and do not constitute financial, investment, legal, or other professional advice. Listeners should not construe any information discussed as a recommendation to buy, sell, or hold any securities or investments. Always consult with a qualified financial advisor or professional before making any financial decisions. Guests may have paid to be on the podcast.
- 1 weeks ago27 min
Niki BioSolutions - $NIKI - Ep:083 - Nano Cap Podcast
Could Alzheimer’s biomarkers help identify risk years before symptoms appear? Will Tjernlund interviews Dr. Alidad Mirskandari of Niki BioSolutions about Alzheimer’s blood test development, early detection, and the path from clinical research to commercially available diagnostics.Dr. Mirskandari shares his journey from biology and genetics to an MBA, consulting, Wall Street, and biotech leadership. He explains Niki BioSolutions’ strategy for pharmaceutical biomarker testing services and its work toward a clinical biomarker panel, subject to validation and clinical utility studies.In this episode, we discuss:How Alzheimer’s biomarkers may change five to twenty years before symptoms emerge.How pharma biomarker testing can support patient recruitment and clinical studies.What it takes to develop lab-developed tests, demonstrate clinical utility, and pursue insurance reimbursement.Why biotech commercialization needs to begin alongside product development.How earlier risk identification could inform monitoring, treatment discussions, and referrals to neurologists.Lessons from the dot-com crash and Dr. Mirskandari’s vision for Niki BioSolutions over the next five years.Listen for a look at the science, business, and reimbursement challenges shaping Alzheimer’s diagnostics and the future of early detection.Niki BioSolutions: https://www.nikibiosolutions.com/Nano Cap Podcast: https://www.nanocappod.com/DISCLAIMER - The contents of this podcast are for informational purposes only and do not constitute financial, investment, legal, or other professional advice. Listeners should not construe any information discussed as a recommendation to buy, sell, or hold any securities or investments. Always consult with a qualified financial advisor or professional before making any financial decisions.
- 2 weeks ago25 min
Birchtech - $BCHT - Ep:082 - Nano Cap Podcast
In this episode, Birchtech CEO Rick MacPherson shares how he helped turn university research into commercial technology that captures mercury from power plant emissions. We discuss the company’s expansion into water treatment to remove PFAS “forever chemicals” and his plans to bring these solutions to more utilities and communities.Birchtech: https://www.birchtech.com/Nano Cap Podcast: https://www.nanocappod.com/DISCLAIMER - The contents of this podcast are for informational purposes only and do not constitute financial, investment, legal, or other professional advice. Listeners should not construe any information discussed as a recommendation to buy, sell, or hold any securities or investments. Always consult with a qualified financial advisor or professional before making any financial decisions.
- 4 weeks ago27 min
Health In Tech - $HIT - Ep:081 - Nano Cap Podcast
In this episode, Tim Johnson, CEO of Health and Tech, shares his journey from insurance industry veteran to innovator leveraging AI and technology to transform health insurance. Discover how his unique approach is shaping the future of self-funded benefits and the role of AI in insurance innovation.Health In Tech: https://healthintech.com/Nano Cap Podcast: https://www.nanocappod.com/DISCLAIMER - The contents of this podcast are for informational purposes only and do not constitute financial, investment, legal, or other professional advice. Listeners should not construe any information discussed as a recommendation to buy, sell, or hold any securities or investments. Always consult with a qualified financial advisor or professional before making any financial decisions.
- Oct 5, 202626 min
Syntholene Energy - $SYNTF - Ep:080 - Nano Cap Podcast
In this episode, Dan Sutton, CEO of Syntholene Energy, discusses the future of synthetic fuels, the potential of small modular reactors, and Iceland's geothermal resources. Discover how innovative energy technologies can revolutionize the global fuel industry and contribute to decarbonization efforts.Syntholene Energy: https://syntholene.com/Nano Cap Podcast: https://www.nanocappod.com/DISCLAIMER - The contents of this podcast are for informational purposes only and do not constitute financial, investment, legal, or other professional advice. Listeners should not construe any information discussed as a recommendation to buy, sell, or hold any securities or investments. Always consult with a qualified financial advisor or professional before making any financial decisions.
Get Nano Cap Podcast summaries in your inbox
Free AI-powered daily recaps. Key takeaways, quotes, and mentions — in a 5-minute read.
Get Free Summaries →Free forever for up to 3 podcasts. No credit card required.
You Might Also Like
Listeners also like.
Uncapped | Benchmark Breakfast
Benchmark
The Best One Yet
A daily 20-minute podcast breaking down the three key business stories with sharp, accessible takes.
The Investor's Podcast (We Study Billionaires) - The Investor’s Podcast Network
Analyzes the investment strategies of billionaire investors and explores lessons from legendary financiers on wealth, wisdom, and life.
TBPN
Daily tech talk show featuring interviews with prominent tech leaders and condensed highlights of key discussions.
The Twenty Minute VC (20VC): Venture Capital | Startup Funding | The Pitch
Interviews with top venture capitalists and successful founders about startup funding and building tech companies.
Stock Movers
Short conversations analyzing today's biggest gainers and losers in global stock markets across major sectors.
David Senra
David Senra hosts conversations with the greatest living founders.
The Compound and Friends
Expert analysis and candid discussions on business and investing trends with a rotating panel of financial professionals.
The NANP Nourishing You Podcast
National Association of Nutrition Professionals (NANP)
Motley Fool Hidden Gems Investing
Daily stock investing insights with long-term business analysis and personal finance interviews.
Right About Now - Legendary Business Advice
Raw business insights from founders and industry leaders, revealing real wins, failures, and actionable strategies without the fluff.
All-In with Chamath, Jason, Sacks & Friedberg
Four tech investors discuss technology, markets, politics, and poker with candid, in-depth analysis.
About Nano Cap Podcast
On the Nano Cap Podcast, we dive into the unique world of publicly traded companies with a market capitalization under $50 million – the nano caps. These are not just numbers on a stock ticker; they are stories of ambition, struggle, and triumph.Each episode, I'll sit down with the leaders and visionaries behind these companies. We’ll uncover the challenges they face, the innovations they bring, and the strategies that drive them forward in a competitive market.
Customized Recaps
AI-powered recaps with compact key takeaways, quotes, and insights.
Straight to Your Inbox
Get key takeaways from Nano Cap Podcast in a 5-minute read.
Save Hours Every Week
Stay current on your favorite podcasts without falling behind.
Frequently Asked Questions
What is Podzilla's Nano Cap Podcast daily summary?
It's a free AI-powered email that summarizes new episodes of Nano Cap Podcast as soon as they're published. You get the key takeaways, notable quotes, and links & mentions — all in a quick read.
How does the Nano Cap Podcast podcast summary work?
When a new episode drops, our AI transcribes and analyzes it, then generates a personalized summary tailored to your interests and profession. It's delivered to your inbox every morning.
Is this an official Nano Cap Podcast product?
No. Podzilla is an independent service that summarizes publicly available podcast content. We're not affiliated with or endorsed by Will Tjernlund.
Can I get summaries of other podcasts too?
Absolutely! The free plan covers up to 3 podcasts, any in the catalog. Basic raises that to 15, Pro to 40 and Max to 100. Browse our full catalog at /podcasts.
How often does Nano Cap Podcast release new episodes?
Nano Cap Podcast publishes biweekly. Our AI generates a summary within hours of each new episode.
What topics does Nano Cap Podcast cover?
Nano Cap Podcast covers topics including Business, Investing. Our AI identifies the specific themes in each episode and highlights what matters most to you.
Start getting Nano Cap Podcast summaries tomorrow morning.
Free forever for up to 3 podcasts. No credit card required.
Free forever for up to 3 podcasts. No credit card required.